CTRI/2021/01/030327
Completed
Phase 1
Role of autologous bone marrow mononuclear stem cells in children with neurological deficits due to polio infection - STEMPO
Department of Biotechnology0 sites5 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Health Condition 1: O- Medical and Surgical
- Sponsor
- Department of Biotechnology
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children between 2 years and 25 years with neurological deficit in the form of defective limb movement and diagnosed as Acute flaccid paralysis due to poliomyelitis by a pediatrician. The patient or his/her guardian giving well informed consent to be included in the blind study
Exclusion Criteria
- •Patients less than 2 years of age or more than 18 years of age. Patients with severe infection with involvement of the respiratory muscles or a chronic source of infection like tonsillitis, UTI. Patients not willing for the study or wanting to drop out later.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)Left Ventricular Function Systolic DysfunctionLeft Ventricular Function Diastolic DysfunctionDeathMyocardial Reperfusion InjuryNCT01307371Xijing Hospital110
Recruiting
Phase 1
A clinical trial to evaluate the effect of bone marrow derived stem cell in diseases like dry age related macular degeneration and retinitis pigmentosaCTRI/2010/091/000639Indian Council Of Medical Research, New Delhi, India50
Completed
Phase 1
Autologous bone marrow derived mononuclear cells transplantation in idiopathic lower limb lymphedema patientsIRCT201611241031N19Royan Institute6
Recruiting
Phase 1
Safety and efficacy of autologous stem cells derived from bone marrow in treating OsteoarthritisCTRI/2010/091/001044International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 56006410
Not yet recruiting
Phase 3
Autologous bone marrow-derived mononuclear cells for therapeutic arteriogenesis in patients with limb ischemia A double blind placebo controlled study in diabetic and non-diabetic patientsclaudication10003216NL-OMON37216eids Universitair Medisch Centrum100